Diatech Pharmacogenetics is proud to announce the certification of its products according to EU 2017/746 regulation on In Vitro Diagnostic Medical Devices (IVDR) – Class C – issued by TÜV SÜD Product Service.
Certification according to EU Regulation 2017/746 (IVDR) is mandatory as of May 26, 2022 for all manufacturers of in vitro diagnostic devices, Class C, to:
- place on the market new products certified for in vitro diagnostic use
- certify products that are subject to substantial changes, such as the addition of new biomarkers in panels already placed on the market for in vitro diagnostic use
Diatech Pharmacogenetics is ready to accept this important challenge, offering customers and patients top quality products in line with European and national regulations.
WE GOT IT!
